These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1668316)

  • 1. Oxytocin but not vasopressin facilitates social recognition following injection into the medial preoptic area of the rat brain.
    Popik P; van Ree JM
    Eur Neuropsychopharmacol; 1991 Dec; 1(4):555-60. PubMed ID: 1668316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactive effects of neurohypophyseal neuropeptides with receptor antagonists on passive avoidance behavior: mediation by a cerebral neurohypophyseal hormone receptor?
    de Wied D; Elands J; Kovács G
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1494-8. PubMed ID: 1847526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system.
    Croiset G; De Wied D
    Brain Res; 1997 Jun; 759(1):18-23. PubMed ID: 9219858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressin and oxytocin receptors on plasma membranes from rat mammary gland. Demonstration of vasopressin receptors by stimulation of inositol phosphate formation, and oxytocin receptors by binding of a specific 125I-labeled oxytocin antagonist, d(CH2)5(1)[Tyr(Me)2, Thr4,Tyr-NH2(9)]OVT.
    Soloff MS; Fernström MA; Fernström MJ
    Biochem Cell Biol; 1989; 67(2-3):152-62. PubMed ID: 2546575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
    Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
    J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term facilitation of social recognition in rats by vasopressin related peptides: a structure-activity study.
    Popik P; Van Ree JM
    Life Sci; 1992; 50(8):567-72. PubMed ID: 1736027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure activity relationship studies with C-terminal fragments of vasopressin and oxytocin on avoidance behaviors of rats.
    de Wied D; Gaffori O; Burbach JP; Kovács GL; van Ree JM
    J Pharmacol Exp Ther; 1987 Apr; 241(1):268-74. PubMed ID: 3572787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low doses of oxytocin facilitate social recognition in rats.
    Popik P; Vetulani J; van Ree JM
    Psychopharmacology (Berl); 1992; 106(1):71-4. PubMed ID: 1738795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid-phase synthesis of 16 potent (selective and nonselective) in vivo antagonists of oxytocin.
    Manning M; Kruszynski M; Bankowski K; Olma A; Lammek B; Cheng LL; Klis WA; Seto J; Haldar J; Sawyer WH
    J Med Chem; 1989 Feb; 32(2):382-91. PubMed ID: 2913298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxytocin pretreatment enhances arginine vasopressin-induced motor disturbances and arginine vasopressin-induced phosphoinositol hydrolysis in rat septum: a cross-sensitization phenomenon.
    Poulin P; Pittman QJ
    J Neuroendocrinol; 1993 Feb; 5(1):33-9. PubMed ID: 8387375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vasopressin, oxytocin and peptides derived from these hormones on field potential induced in lateral septum of rats by stimulation of the fimbria fornix.
    Urban IJ; De Wied D
    Neuropeptides; 1986 Jan; 7(1):41-9. PubMed ID: 3951680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a D-Cys6/L-Cys6 interchange in nonselective and selective vasopressin and oxytocin antagonists.
    Manning M; Cheng LL; Klis WA; Balaspiri L; Olma A; Sawyer WH; Wo NC; Chan WY
    J Med Chem; 1995 May; 38(10):1762-9. PubMed ID: 7752199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurohypophyseal hormone receptors in the septum are implicated in social recognition in the rat.
    Popik P; Vos PE; Van Ree JM
    Behav Pharmacol; 1992 Aug; 3(4):351-358. PubMed ID: 11224137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of oxytocin receptors, but not arginine-vasopressin V1a receptors, in the ventral tegmental area of male Syrian hamsters is essential for the reward-like properties of social interactions.
    Song Z; Borland JM; Larkin TE; O'Malley M; Albers HE
    Psychoneuroendocrinology; 2016 Dec; 74():164-172. PubMed ID: 27632574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral effects of vasopressin and oxytocin within the medial preoptic area of the golden hamster.
    Albers HE; Ferris CF
    Regul Pept; 1985 Nov; 12(3):257-60. PubMed ID: 4081129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the influence of vasopressin neuropeptides on social recognition of rats.
    Sekiguchi R; Wolterink G; van Ree JM
    Eur Neuropsychopharmacol; 1991 May; 1(2):123-6. PubMed ID: 1821701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxytocin (OT) and arginine-vasopressin (AVP) act on OT receptors and not AVP V1a receptors to enhance social recognition in adult Syrian hamsters (Mesocricetus auratus).
    Song Z; Larkin TE; Malley MO; Albers HE
    Horm Behav; 2016 May; 81():20-7. PubMed ID: 26975586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasopressin interactions with oxytocin in the control of female sexual behavior.
    Pedersen CA; Boccia ML
    Neuroscience; 2006; 139(3):843-51. PubMed ID: 16488546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopressin-induced sensitization: involvement of neurohypophyseal peptide receptors.
    Poulin P; Szot P; Dorsa DM; Pittman QJ
    Eur J Pharmacol; 1995 Dec; 294(1):29-39. PubMed ID: 8788413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxytocin-stimulated release of adrenocorticotropin from the rat pituitary is mediated by arginine vasopressin receptors of the V1b type.
    Schlosser SF; Almeida OF; Patchev VK; Yassouridis A; Elands J
    Endocrinology; 1994 Nov; 135(5):2058-63. PubMed ID: 7956927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.